Authors:
Colita, A
Belhabri, A
Chelghoum, Y
Charrin, C
Fiere, D
Thomas, X
Citation: A. Colita et al., Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: A retrospective study of 54 cases, ANN ONCOL, 12(4), 2001, pp. 451-455
Authors:
Thiebaut, A
Thomas, X
Belhabri, A
Anglaret, B
Archimbaud, E
Citation: A. Thiebaut et al., Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis, ANN HEMATOL, 79(9), 2000, pp. 501-506
Authors:
Michallet, M
Thiebaut, A
Philip, I
Charrin, C
Vigouroux, C
Thomas, X
Bilger, K
Belhabri, A
Guyotat, D
Corront, B
Salles, B
Dumontet, C
Peaud, PY
Vilque, JP
Devidas, A
Fiere, D
Citation: M. Michallet et al., Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha, LEUKEMIA, 14(12), 2000, pp. 2064-2069
Authors:
Thomas, X
Troncy, J
Belhabri, A
Thiebaut, A
Bouheddou, N
Michallet, M
Fleurette, J
Pivot, C
Fiere, D
Archimbaud, E
Citation: X. Thomas et al., A double-blind randomized study evaluating the vancomycin-pefloxacin combination as a gastrointestinal tract decontaminant for the prevention of infections in patients with chemotherapy-induced neutropenia, PRESSE MED, 29(32), 2000, pp. 1745-1751
Authors:
Michallet, M
Thomas, X
Vernant, JP
Kuentz, M
Socie, G
Esperou-Bourdeau, H
Milpied, N
Blaise, D
Rio, B
Reiffers, J
Jouet, JP
Cahn, JY
Bourhis, JH
Lioure, B
Leporrier, M
Sotto, JJ
Souillet, G
Sutton, L
Bordigoni, P
Dreyfus, F
Tilly, H
Gratecos, N
Attal, M
Leprise, PY
Demeocq, F
Michel, G
Buzyn, A
Delmas-Marsalet, B
Bernaudin, F
Ifrah, N
Sadoun, A
Guyotat, D
Cavazzana-Cavo, M
Caillot, D
De Revel, T
Vannier, JP
Baruchel, A
Fegueux, N
Tanguy, ML
Thiebaut, A
Belhabri, A
Archimbaud, E
Citation: M. Michallet et al., Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM), BONE MAR TR, 26(11), 2000, pp. 1157-1163
Authors:
Michallet, M
Thiebaut, A
Dreger, P
Remes, K
Milpied, N
Santini, G
Hamon, M
Bjorkstrand, B
Kimby, E
Belhabri, A
Tanguy, ML
Apperley, JF
Citation: M. Michallet et al., Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalfof the EBMT Chronic Leukaemias Working Party (CLWP), BR J HAEM, 108(3), 2000, pp. 595-601
Authors:
Michallet, M
Tanguy, ML
Socie, G
Thiebaut, A
Belhabri, A
Milpied, N
Reiffers, J
Kuentz, M
Cahn, JY
Blaise, D
Demeocq, F
Jouet, JP
Michallet, AS
Ifrah, N
Vilmer, E
Molina, L
Michel, G
Lioure, B
Cavazzana-Calvo, M
Pico, JL
Sadoun, A
Guyotat, D
Attal, M
Cure, H
Bordigoni, P
Sutton, L
Buzyn-Veil, A
Tilly, M
Leporrier, M
Fegueux, N
Dreyfus, F
Rio, B
Lutz, P
Vernant, JP
Citation: M. Michallet et al., Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM), BR J HAEM, 108(2), 2000, pp. 400-407
Authors:
Thomas, X
Teillon, MH
Belhabri, A
Rimokh, R
Fiere, D
Magaud, JP
Archimbaud, E
Citation: X. Thomas et al., Hypermethylation of calcitonin gene in adult acute leukemia at diagnosis and during complete remission, HEM CELL TH, 41(1), 1999, pp. 19-26
Authors:
Belhabri, A
Thomas, X
Troncy, J
Assouline, D
Michallet, M
Wattel, E
Tigaud, JD
Blanc, M
Fiere, D
Archimbaud, E
Citation: A. Belhabri et al., Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study, LEUK LYMPH, 36(1-2), 1999, pp. 45-55
Authors:
Archimbaud, E
Jehn, U
Thomas, X
De Cataldo, F
Fillet, G
Belhabri, A
Peaud, PY
Martin, C
Amadori, S
Willemze, R
Citation: E. Archimbaud et al., Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction consolidation therapy, followedby a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia, LEUKEMIA, 13(6), 1999, pp. 843-849
Authors:
Michallet, M
Perrin, MC
Belhabri, A
Molina, L
Nicolini, F
Tigaud, JD
Sotto, JJ
Guyotat, D
Fiere, D
Archimbaud, E
Citation: M. Michallet et al., Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation, BONE MAR TR, 23(2), 1999, pp. 145-150